Valsartan D9
| Product Name | Valsartan D9 |
|---|---|
| Alternate Names | Valsartan Stable Isotopes, Stable Isotopes of Valsartan |
| CAT No. | CS-O-02862 |
| CAS No. | 1089736-73-1 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 444.57 g/mol |
| Mol. For. | C₂₄H₂₀D₉N₅O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Valsartan |
| Purity | 95% |
| Therapeutic | Anti-Hypertensives |
| Smileys | O=C(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])N([C@H](C(O)=O)C(C)C)CC1=CC=C(C2=C(C3=NN=NN3)C=CC=C2)C=C1 |
| Canonical Smiles | CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O |
| InchIKey | ACWBQPMHZXGDFX-KDDXQTGLSA-N |
| Inchl | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1/i1D3,4D2,5D2,10D2 |
| IUPAC | (2S)-3-methyl-2-[2,2,3,3,4,4,5,5,5-nonadeuteriopentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Valsartan D9 is a deuterated form of the angiotensin II receptor antagonist Valsartan. It is an antihypertensive medication that is used to treat high blood pressure, heart failure, and to reduce the risk of death after a heart attack. Valsartan D9 works by blocking the action of angiotensin II, a hormone that causes blood vessels to narrow and raises blood pressure.
Chemically, Valsartan D9 is a white to off-white crystalline powder that is sparingly soluble in water. Its molecular formula is C24H24D9N5O3, and its molecular weight is 451.6 g/mol. The deuterium substitution in Valsartan D9 does not significantly affect its pharmacological properties but enhances the specificity of its analysis in biological samples by mass spectrometry.
The recommended dosage of Valsartan D9 varies depending on the condition being treated and the patient's age, weight, and medical history. It is usually taken orally once or twice a day, with or without food. The medication is metabolized in the liver and excreted in the feces and urine, with a half-life of about 6 hours.
Like other medications, Valsartan D9 may cause side effects such as dizziness, headache, diarrhea, fatigue, and cough. It may also interact with other drugs, including diuretics, potassium supplements, and nonsteroidal anti-inflammatory drugs (NSAIDs).
In conclusion, Valsartan D9 is a useful medication for managing hypertension and heart failure. Its deuterated form allows for more accurate and sensitive analysis in biological samples. However, patients should be aware of its potential side effects and drug interactions and should consult their healthcare provider before taking this medication.
Get an Instant Quote
Related Compounds
Valsartan D3 | Valsartan D8 |